Search results
Paul R. Edick joined Xeris Pharmaceuticals as Chairman and Chief Executive Officer in January 2017. Prior to Xeris, Mr. Edick was Founding Partner of 3G Advisors, a consultancy to the pharmaceutical, healthcare, and healthcare investor communities.
May 9, 2019 · This summer, the company plans to commercialize its first product, which delivers the life-saving hormone glucagon to people with diabetes who experience a severe drop in blood sugar. Below are some of our key takeaways from Paul’s talk. An ‘accidental’ leap into healthcare.
Paul R. Edick joined Xeris Pharmaceuticals as Chairman and Chief Executive Officer in January 2017. Prior to Xeris, Mr. Edick was Founding Partner of 3G Advisors, a consultancy to the pharmaceutical, healthcare, and healthcare investor communities.
Jan 31, 2024 · Paul Raymond Edick serves as Chairman of the Board, Chief Executive Officer of the Company. Prior to XERIS Pharmaceuticals, Mr. Edick was Founding Partner of 3G Advisors, a consultancy to the pharmaceutical, healthcare and healthcare investor communities.
- How Did The Covid-19 Pandemic Impact Xeris?
- Was The Manufacturing Affected at All?
- Is A Pramlintide-Insulin Combo Something That Is Still in The Xeris Pipeline?
- Thanks Again For Your Time today. Any Final Thoughts You’D Like to End on?
It’s been tough. The entire healthcare world has been impacted. In the first half of March 2020, it was pretty clear that things were going to shut down. I was on the road and actually called the office and said, “Okay, pull everybody from the field.” And that weekend we instituted a totally virtual platform for the salesforce so that the next week...
Luckily the manufacturing was not affected by the pandemic. We were concerned early on for Gvoke HypoPen because the parts are manufactured in Taiwan, but they didn’t have a work stoppage. If there had been, it would have delayed the launch. The Pre-filled Syringe is made here in the States and has had no disruptions. We’re lucky.
Absolutely. I think it could be one fantastic drug. The reason I say that is the original promise of pramlintide was that as a co-administration with insulin, it would help insulin work harder and you’d have to use less insulin. But the co-administration has not worked very well because it requires a lot of titration. And it never fulfilled its pro...
Our message for the community is ask your doctor for glucagon. If you’re on insulin, you’re at risk for severe hypoglycemia. Maybe you’ve been on insulin for 20 years and you’ve never had a severe hypo, but that doesn’t mean you won’t have one. Talk to your physician. Be safe. Be prepared.
View Paul Edick’s profile on LinkedIn, the world’s largest professional community. Paul has 3 jobs listed on their profile.
- 698 followers
Nov 10, 2021 · Good morning. And welcome to Xeris’ third quarter 2021 financial results and corporate update conference call and webcast. A press release with the company’s third quarter financial results was...
